GE HealthCare Technologies Inc. (GEHC) — Analyst outlook / Analyst consensus target is. Based on 17 analyst ratings, the consensus is bullish — 11 Buy, 5 Hold, 1 Sell.
The consensus price target is $91.70 (low: $77.00, high: $105.00), representing an upside of 22.8% from the current price $74.67.
Analysts estimate Earnings Per Share (EPS) of $4.30 and revenue of $19.68B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $4.37 vs est $4.30 (beat +1.7%). 2025: actual $4.56 vs est $4.55 (beat +0.2%). Analyst accuracy: 99%.
GEHC Stock — 12-Month Price Forecast
$91.70
▲ +22.81% Upside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for GE HealthCare Technologies Inc., the average price target is $91.70, with a high forecast of $105.00, and a low forecast of $77.00.
The average price target represents a +22.81% change from the last price of $74.67.
Highest Price Target
$105.00
Average Price Target
$91.70
Lowest Price Target
$77.00
GEHC Analyst Ratings
Buy
Based on 17 analysts giving stock ratings to GE HealthCare Technologies Inc. in the past 3 months
EPS Estimates — GEHC
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.37
vs Est $4.30
▲ 1.7% off
2025
Actual $4.56
vs Est $4.55
▲ 0.2% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — GEHC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $19.672B
vs Est $19.677B
▼ 0.0% off
2025
Actual $20.625B
vs Est $20.534B
▲ 0.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
